Compound 964
Identifiers
- Canonical SMILES: 
CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCN(Cc2ccccc2C)CC1
 - IUPAC name: 
N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonyl-4-[4-[(2-methylphenyl)methyl]piperazin-1-yl]benzamide
 - InChi: 
InChI=1S/C37H44N6O5S2/c1-28-9-7-8-10-30(28)26-41-21-23-42(24-22-41)32-15-13-29(14-16-32)37(44)39-50(47,48)34-17-18-35(36(25-34)43(45)46)38-31(19-20-40(2)3)27-49-33-11-5-4-6-12-33/h4-18,25,31,38H,19-24,26-27H2,1-3H3,(H,39,44)/t31-/m1/s1
 - InChiKey: 
SMQYDTWNUNHOFH-WJOKGBTCSA-N
 
External links
        
        ![]() 16109090  | 
      
        
        ![]() CHEMBL387142  | 
      
        
        ![]() 17266504  | 
      
External search
         
       | 
      
         
       | 
      
           
       | 
      
           
       | 
      
           
       | 
    
Bibliography (1)
Pharmacological data
| Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests | 
|---|---|---|---|
| 2 | 0 | 0 | 0 | 
Targets
| PPI family | Best activity | Diseases | MMoA | 
|---|---|---|---|
| BCL2-Like / BAX | 8.52 | cancer | Inhibition | 
Physicochemical filters
| Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
|---|---|---|---|---|
| Compliance | ||||
| MW | 716.28 g/mol | |||
| HBA | 11 | |||
| HBD | 2 | |||
| HBA + HBD | 13 | |||
| AlogP | 5.75 | |||
| TPSA | 130.81 | |||
| RB | 14 | 
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
| Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests | 
|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 
Pharmacological data
| Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity | 
|---|---|---|---|---|---|---|---|---|
| 17256834 | 23b | BCL2  P10415  | 
                      | 
                    Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 8.35 | |
| 17256834 | 23b | B2CL1  Q07817  | 
                      | 
                    Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 8.52 | 
| Ta | Structure | Name | Drugbank ID | 
|---|---|---|---|
| 0.5394 | Navitoclax | DB12340 | |
| 0.4634 | Venetoclax | DB11581 | |
| 0.4562 | Sulfabenzamide | DB09355 | |
| 0.4294 | (2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine | DB07049 | |
| 0.4270 | 3-Nitro-4-(2-Oxo-Pyrrolidin-1-Yl)-Benzenesulfonamide | DB04394 | |
| 0.4118 | CNV-2197944 | DB15229 | |
| 0.4101 | 2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid | DB07691 | |
| 0.4012 | Saccharin | DB12418 | |
| 0.4000 | Nelfinavir | DB00220 | |
| 0.3956 | SC-74020 | DB01630 | |
| 0.3905 | N-[4-(AMINOSULFONYL)PHENYL]-2-MERCAPTOBENZAMIDE | DB07476 | |
| 0.3894 | Amisulpride | DB06288 | |
| 0.3886 | Thioproperazine | DB01622 | |
| 0.3883 | [4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID | DB07986 | |
| 0.3816 | 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid | DB03124 | 




